Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.CSCI
Alternate Symbol(s):
CSCI
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CSCI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Nov 21, 2024 1:04pm
RE:RE:Email Response from Gilles Gagnon on March 12, 2024
Gilles actually knows the cards the company is holding better than anyone. If he's convinces that can be a great sign. We've never seen the data for the pill or the discussions with potential
...more
(2119)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Nov 21, 2024 1:03pm
RE:Email Response from Gilles Gagnon on March 12, 2024
Gagnon's gotta go
(2011)
•••
Ciao
X
View Profile
View Bullboard History
Comment by
Ciao
on Nov 21, 2024 12:30pm
RE:RE:Email Response from Gilles Gagnon on March 12, 2024
Gilles has proven himself that he can't execute a business plan even if he had a legitimate one. I've chronicled his failures over the years. He is just incompetent. A change in leadership a
...more
(30)
•••
Stinzo
X
View Profile
View Bullboard History
Comment by
Stinzo
on Nov 21, 2024 12:06pm
RE:Email Response from Gilles Gagnon on March 12, 2024
I dont know Oats, seems very arrogant to me especially with no track record and no positive momentum for years, 10+ years that is. we are unfortunately stuck until something gives I guess
...more
(13)
•••
oats
X
View Profile
View Bullboard History
Post by
oats
on Nov 21, 2024 10:48am
Email Response from Gilles Gagnon on March 12, 2024
Below is the response that Gilles Gagnon provided on March 12, 2024 with regards to my message to him regarding the Merger: Hi XXXXXX, While I read that you will never forgive me and the board for
...more
(13)
•••
oats
X
View Profile
View Bullboard History
Comment by
oats
on Nov 21, 2024 9:34am
RE:RE:RE:RE:RE:Email to Gilles Gagnon on March 7, 2024
Stinzo, I do see value here simply based on the cash, my estimate, which I think is quite accurate is that they should have no less that $22.5 million US in cash. This equates to about $6 per
...more
•••
Jonathon Brown
X
View Profile
View Bullboard History
Post by
Jonathon Brown
on Nov 21, 2024 6:55am
Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed
A highlight of the week was Bombardier (TSX:BBD), which reported impressive growth in its Q3 2024 results.
read article.
(30)
•••
Stinzo
X
View Profile
View Bullboard History
Comment by
Stinzo
on Nov 21, 2024 6:21am
RE:RE:RE:RE:Email to Gilles Gagnon on March 7, 2024
Thank you very much Oats for the background. Even if you had not shared, i think most long term shareholders would have come to a similar conclusion. Very sad, for all the lost money
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Nov 20, 2024 8:15pm
Avenanthramide
What happened to avenanthramide sales? One possibility is that the amount if avenanthramide was changed after the spin-off from J&J. This could create an opportunity for Juvente. Perplexity Ai
...more
(2011)
•••
Ciao
X
View Profile
View Bullboard History
Comment by
Ciao
on Nov 20, 2024 7:29pm
RE:RE:RE:Email to Gilles Gagnon on March 7, 2024
Oats, we were told prior to any "merger" activtiy that Ceapro had adequate funds to prioritize it's projects with cash on hand. If AV sales which we said to rebound did occur then cash
...more
(13)
•••
oats
X
View Profile
View Bullboard History
Comment by
oats
on Nov 20, 2024 7:04pm
RE:RE:Email to Gilles Gagnon on March 7, 2024
That is easy Ciao. They pissed away so much money on legal fees prior to announcing the deal, lower sales, and initiative $$ requirements were decimating the cash level of the company. Based on
...more
(2011)
•••
Ciao
X
View Profile
View Bullboard History
Comment by
Ciao
on Nov 20, 2024 6:19pm
RE:Email to Gilles Gagnon on March 7, 2024
Oats, thanks for sharing your thoughts in this email to Gilles. I'll let you decide if you want to share any details for your statement with regards to the merger "You forced the hand of my
...more
(13)
•••
oats
X
View Profile
View Bullboard History
Post by
oats
on Nov 20, 2024 5:42pm
Email to Gilles Gagnon on March 7, 2024
If you are interested in my exact thoughts on the Merger, please see below for the message sent to Gilles on March 7, 2024. I will post the response that I got tomorrow. Hi Gilles, As
...more
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Nov 20, 2024 7:36am
RE:RE:RE:RE:RE:RE:RE:RE:RE:Cash
Yes that was in 02/2021 where they also forecasted 2 market launches within 18 months as well as estimating the immune booster market would see 40 % annuel increase until 2030 due to
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Nov 19, 2024 5:52pm
RE:RE:RE:RE:RE:RE:RE:RE:Cash
They've provided a net present value analysis previously for a 40 million dose immune booster plant.
(30)
•••
Stinzo
X
View Profile
View Bullboard History
Comment by
Stinzo
on Nov 19, 2024 2:51pm
RE:RE:RE:RE:RE:RE:RE:RE:Cash
I was going to say the same thing ... complete a 2 year merger with no planning ...
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden